This study aimed to compare the intent to undergo BRCA1/2 testing, risk-reducing salpingo-oophorectomy (RRSO), and risk-reducing mastectomy (RRM) among the general public, cancer patients, and healthcare professionals in Korea. Here, BRCA1 is linked to cancer.